Clinical Trial Detail

NCT ID NCT01858168
Title Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Massachusetts General Hospital
Indications

Ewing sarcoma

Therapies

Olaparib + Temozolomide

Age Groups: adult

No variant requirements are available.